This inventor holds 1 USPTO granted patent. Top assignees: Centre Hospitalier Universitaire De Clermont-Fd, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 5,383 
1 out of 1,853 
Years Active: 2025
Title: Radhouane Dallel: Innovator in Pain Treatment
Introduction
Radhouane Dallel is a notable inventor based in Clermont-Ferrand, France. He has made significant contributions to the field of therapeutics, particularly in the treatment of pain. His innovative work has led to the development of novel compounds that hold promise for medical applications.
Latest Patents
Radhouane Dallel holds 1 patent for his invention titled "Pyridin-2(1H)one derivatives, their preparation and their use for the treatment of pain." This patent focuses on new pyridin-2(1H)one derivatives, detailing their preparation processes and therapeutic uses, especially as agents for treating and preventing pain.
Career Highlights
Throughout his career, Radhouane Dallel has worked with esteemed organizations such as Sigma Clermont and the Centre National de la Recherche Scientifique. His roles in these institutions have allowed him to advance his research and contribute to the scientific community.
Collaborations
Radhouane has collaborated with notable colleagues, including Francis Giraud and Fabrice Anizon. These partnerships have enriched his research endeavors and fostered innovation in his field.
Conclusion
Radhouane Dallel's work exemplifies the impact of innovative research in pain management. His contributions continue to influence the development of therapeutic agents aimed at improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile